SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-11-048902
Filing Date
2011-09-12
Accepted
2011-09-12 18:39:10
Documents
1
Period of Report
2011-09-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd321255.html 3  
1 FORM 3 rrd321255.xml 3 1525
  Complete submission text file 0001181431-11-048902.txt   2879
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Issuer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address
McMahon Gerald PhD (Reporting) CIK: 0001290747 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21990 | Film No.: 111086586